Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDW.L Share News (RDW)

  • There is currently no data for RDW

RDW.L News

LONDON MARKET MIDDAY: Barratt and Smurfit Kappa bookend FTSE 100
7 Feb 2024

LONDON MARKET MIDDAY: Barratt and Smurfit Kappa bookend FTSE 100

(Alliance News) - Stock prices in London were lower at midday Wednesday, with Barratt Developments and Smurfit Kappa sitting either side of the FTSE 1...

Barratt agrees GBP2.5 billion Redrow takeover amid strain on sector
7 Feb 2024

Barratt agrees GBP2.5 billion Redrow takeover amid strain on sector

(Alliance News) - Analys were eyeing Barratt Developments PLC's GBP2.5 billion takeover offer for smaller peer Redrow PLC on Wednesday, as housebuilde...

LONDON MARKET OPEN: Barratt agrees GBP2.5 billion Redrow takeover
7 Feb 2024

LONDON MARKET OPEN: Barratt agrees GBP2.5 billion Redrow takeover

(Alliance News) - Stock prices in London opened lower on Wednesday, after housebuilder Barratt offered to buy FTSE 250 rival Redrow in a takeover deal...

TOP NEWS: Barratt agrees Redrow takeover as both report fall in sales
7 Feb 2024

TOP NEWS: Barratt agrees Redrow takeover as both report fall in sales

(Alliance News) - Barratt Developments PLC on Wednesday said it agreed the terms of an all-share takeover offer for smaller peer Redrow PLC, valuing R...

LONDON BRIEFING: Barratt takes over Redrow in GBP2.5 billion deal
7 Feb 2024

LONDON BRIEFING: Barratt takes over Redrow in GBP2.5 billion deal

(Alliance News) - Stocks in London are called to open slightly higher on Wednesday, with all eyes on the property sector.

Barratt, Redrow agree £2.5bn merger
7 Feb 2024

Barratt, Redrow agree £2.5bn merger

(Sharecast News) - Britain's biggest housebuilder Barratt said it had agreed an all-share takeover of smaller rival Redrow valuing the latter at £...

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca
16 Jan 2024

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: